本文源自：智通财经网 智通财经获悉，建滔系绩后下挫，截至发稿，建滔积层板(01888)跌8.19%，报12港元；建滔集团(00148) 跌6.25%，报28.8港元。 消息面上，建滔集团午间公布2025年中期业绩，营业额约216.08亿港元，同比增长6%；公司持有人应 占纯利约25.82亿港元，同比增长71%；每股基本盈利2.329港元，每股中期股息0.69港元。建滔积层板 同样发布2025年中期业绩，该公司上半年取得营业额95.88亿港元，同比增加11%；公司持有人应占纯 利9.33亿港元，同比增加28%；每股基本盈利29.9港仙，拟派发中期股息每股15港仙。 ...

Core Viewpoint - The stock prices of Kwan Tong Group and Kwan Tong Laminates fell significantly after the announcement of their mid-year results for 2025, indicating market reaction to the earnings report [1] Group 1: Kwan Tong Group Performance - Kwan Tong Group reported a revenue of approximately HKD 21.608 billion for the mid-year of 2025, representing a year-on-year growth of 6% [1] - The attributable net profit for Kwan Tong Group was approximately HKD 2.582 billion, showing a substantial increase of 71% year-on-year [1] - Basic earnings per share were HKD 2.329, with an interim dividend of HKD 0.69 per share proposed [1] Group 2: Kwan Tong Laminates Performance - Kwan Tong Laminates achieved a revenue of HKD 9.588 billion in the first half of 2025, which is an increase of 11% compared to the previous year [1] - The attributable net profit for Kwan Tong Laminates was HKD 933 million, reflecting a year-on-year growth of 28% [1] - Basic earnings per share were HKD 0.299, and an interim dividend of HKD 0.15 per share was proposed [1]

Core Viewpoint - Kintor Group (00148) reported a strong performance for the first half of 2025, with significant growth in revenue and profit driven by robust demand in the electronics market, particularly in AI-related products [1] Financial Performance - Revenue for the period was approximately HKD 21.608 billion, representing a year-on-year increase of 6% [1] - Profit attributable to shareholders was around HKD 2.582 billion, showing a substantial year-on-year growth of 71% [1] - Basic earnings per share were HKD 2.329, with an interim dividend of HKD 0.69 per share [1] Market Demand and Product Performance - The overall demand in the electronics market was strong, with rapid development in high-end sectors such as AI [1] - Emerging electronic products related to AI saw particularly strong demand, boosting the sales of copper-clad laminate and printed circuit board products [1] - Both segments experienced profit growth compared to the same period last year [1] Investment Business - The investment business segment also reported profit growth compared to the previous year [1] - The company's competitive advantages stem from its vertically integrated supply chain and diversified business portfolio [1] - The efforts of Kintor's team contributed to achieving over HKD 2.5 billion in net profit [1]

Core Viewpoint - The company reported a strong financial performance for the first half of 2025, driven by robust demand in the electronic market, particularly in AI-related products, leading to significant profit growth [1] Financial Performance - The company achieved a revenue of approximately HKD 21.608 billion, representing a year-on-year increase of 6% [1] - The profit attributable to shareholders was around HKD 2.582 billion, marking a substantial year-on-year growth of 71% [1] - Basic earnings per share were HKD 2.329, with an interim dividend of HKD 0.69 per share [1] Market Demand and Product Performance - Overall demand in the electronic market was strong, with rapid development in high-end sectors such as AI [1] - The demand for emerging electronic products related to AI was particularly robust, contributing to the growth in the company's copper-clad laminate and printed circuit board products [1] - Both segments experienced profit increases compared to the same period last year [1] Investment Business - The company's investment business segment also saw profit growth compared to the previous year [1] Competitive Advantages - The company's success is attributed to the efforts of its team, a vertically integrated business model, and a diversified business portfolio, which provided a competitive edge [1]

回顾期内，整体电子市场需求畅旺，AI人工智能等高端领域快速发展，围绕AI人工智能概念的新兴电 子产品更是需求强劲，带动集团覆铜面板产品及印刷线路板产品的需求增长，两个部门的利润均较去年 同期提升。另外，集团投资业务部门的利润也较去年同期录得增长。同时有赖建滔同仁努力不懈，加上 集团垂直整合产业链之经营模式及多元化之业务组合的竞争优势，集团收获超过二十五亿的纯利。 格隆汇8月25日丨建滔集团(00148.HK)公布中期业绩，2025年上半年，集团营业额较去年同期上升6%至 216.08亿港元，公司持有人应占纯利上升71%至25.82亿港元。董事会决定派发中期股息每股69港仙。 ...

第 1 頁 共 2 頁 v 1.1.1 EF001 EF001 免責聲明 其他信息 其他信息 不適用 發行人董事 董事會成員包括本公司執行董事張國榮先生、鄭永耀先生、張廣軍先生、何燕生先生、張家成先生、何建芬女士及陳茂盛先生、及 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 建滔集團有限公司 | | 股份代號 | 00148 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 截至二零二五年六月三十日止六個月之中期股息 | | | 公告日期 | 2025年8月25日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 中期（半年期） | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年6月30日 | | 宣派股息 | 每 ...

香港交易及結算所有限公司以及香港聯合交易所有限公司對本公佈之內容概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 會 就 因 本 公佈全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任 何 責 任。 KINGBOARD HOLDINGS LIMITED 建滔集團有限公司 （於 開 曼 群 島 註 冊 成 立 之 有 限 公 司） （股 份 代 號：148） 中期業績公佈 | 財務摘要 | | | | | --- | --- | --- | --- | | | 截至六月三十日止六個月 | | | | | 二零二五年 | 二零二四年 | 變動 | | | 百萬港元 | 百萬港元 | | | 營業額 | 21,608.3 | 20,415.2 | +6% | | 未 扣 除 利 息、稅 項、折 舊 及 | | | | | 攤銷前盈利 | 4,771.2 | 3,736.0 | +28% | | 除稅前溢利 | 3,174.0 | 2,138.7 | +48% | | 本公司持有人應佔純利 | 2,581.6 | 1,506.9 | +71% ...

Core Viewpoint - Country Garden (碧桂园) has swiftly acted on the recently relaxed refinancing policies for listed real estate companies by announcing a new share issuance to convert part of its debt into equity, thereby improving its financial position [1][4]. Group 1: Share Issuance Details - Country Garden plans to issue 351 million new shares at a price of HKD 0.77 per share, representing a discount of approximately 15.38% from the closing price of HKD 0.91 on August 29 [1]. - The total consideration for the new shares amounts to HKD 270 million, which will account for about 1.27% of the existing issued share capital and approximately 1.25% of the total share capital post-issuance [1]. Group 2: Purpose and Implications of the Issuance - The proceeds from the share issuance will be used to offset part of the amounts owed to the subscriber under a financing agreement, meaning the company will not receive cash from this transaction [3]. - This issuance is effectively a "debt-to-equity swap," allowing the subscriber to convert part of its debt into shares, which will help Country Garden to capitalize on certain payment amounts and reduce cash outflows [3][4]. Group 3: Subscriber Information - The subscriber is a limited company registered under Hong Kong law, fully owned by Kwan Hung Group (建滔集团), which primarily engages in investment holding [3]. - Kwan Hung Group operates through five divisions, including manufacturing and sales of chemical products, property development, and investment [3][4]. Group 4: Financial Position and Future Outlook - Following the completion of the subscription, the outstanding principal amount owed by Country Garden to the subscriber will be HKD 1.598 billion, which will be repaid in installments, with the final payment due in December 2023 [4]. - The recent refinancing actions coincide with favorable policies announced by the China Securities Regulatory Commission, which have eased restrictions on refinancing for real estate companies [4][5]. Group 5: Additional Corporate Actions - On August 25, Country Garden announced the sale of a 26.67% stake in the Guangzhou Asian Games City project to China Overseas for approximately HKD 1.29 billion, expected to yield a pre-tax profit of about HKD 500 million [5]. - The company has initiated a second bondholders' meeting for the "16碧园05" bond, proposing a 40-day grace period for the repayment of principal and/or interest due on September 2 [5].

致：香港交易及結算所有限公司 公司名稱: 建滔集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 截至月份: 2025年7月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00148 | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | | 0.1 HKD | | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | | 本月底結存 | | | 2,000,000,000 | HKD | | | 0.1 HKD | | | 200,000, ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index dropping over 1%, ending a five-day winning streak, closing at 25,388.35 points, down 1.09% or 278.83 points, with a total turnover of 281.77 billion HKD [1] - Despite the decline, the Hang Seng Index saw a weekly increase of 2.27%, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index rose by 1.83% and 2.51% respectively [1] Blue Chip Performance - WuXi Biologics (02269) led the blue-chip stocks, rising 5.53% to 31.5 HKD, contributing 9.65 points to the Hang Seng Index, following a profit warning indicating a projected 16% revenue growth in the first half of 2025 [2] - Other notable blue-chip performances included SMIC (00981) up 4.98%, Nongfu Spring (09633) up 3.56%, while New Oriental (09901) and Shenzhou International (02313) saw declines of 3.36% and 2.94% respectively [2] Sector Highlights - Large tech stocks generally declined, with Alibaba down nearly 2% and Tencent over 1% [3] - Semiconductor stocks saw a rally, with Hua Hong Semiconductor rising 9% and SMIC up nearly 5% [3] - The pharmaceutical sector experienced gains, driven by a shift towards value assessment in drug procurement, with notable increases in stocks like Kanglong Chemical (03759) up 7.71% and Zhaoyan New Drug (06127) up 7.02% [4] - Airline stocks were active, with China Eastern Airlines (00670) up 3.69% and Air China (00753) up 3.68%, supported by strong summer travel demand [6][7] Regulatory Developments - The National Healthcare Security Administration announced changes to the 11th batch of centralized procurement, moving away from a simple lowest price reference, which is expected to curb vicious price competition and promote a shift towards value-based competition in the pharmaceutical industry [5] - The introduction of new policies aimed at supporting innovative drugs and medical devices was discussed in a recent meeting, indicating a focus on enhancing the clinical application of high-level technological innovations [5] Notable Stock Movements - Valiant Biopharma (09887) saw a significant increase of 91.71% on its debut, closing at 67.1 HKD, following a successful IPO [9] - Jihong Holdings (02603) rose 15.31% after announcing a projected net profit increase of 97.25% to 108.21% for the first half of 2025 [10] - COSCO Shipping Ports (01199) reached a new high, up 9.31%, amid reports of potential acquisitions of port assets [11] - Kintor Pharmaceutical (00148) announced a profit warning, leading to an 8.29% increase in stock price, with expected profits rising over 70% [12] - Lingbao Gold (03330) also saw gains, up 5.89%, with projected revenue growth of 75% to 85% for the first half of 2025 [13]